Format
Sort by

Send to

Choose Destination

Selected items

Items: 5

1.

CD59 efficiently protects human NT2-N neurons against complement-mediated damage.

Pedersen ED, Aass HC, Rootwelt T, Fung M, Lambris JD, Mollnes TE.

Scand J Immunol. 2007 Aug-Sep;66(2-3):345-51.

2.

Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.

Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT.

J Immunol. 2006 Sep 15;177(6):4094-102.

3.

Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia.

Kaminski HJ, Kusner LL, Richmonds C, Medof ME, Lin F.

Exp Neurol. 2006 Dec;202(2):287-93. Epub 2006 Jul 20.

PMID:
16859686
4.

Complement activation in diabetic ketoacidosis brains.

Hoffman WH, Cudrici CD, Zafranskaia E, Rus H.

Exp Mol Pathol. 2006 Jun;80(3):283-8. Epub 2006 Feb 21.

PMID:
16494864
5.

Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis.

Williams AS, Mizuno M, Richards PJ, Holt DS, Morgan BP.

Arthritis Rheum. 2004 Sep;50(9):3035-44.

Supplemental Content

Support Center